Literature DB >> 8931982

Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.

M Polihronis1, B F Murphy, M J Pearse, D A Power.   

Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is one of five well-described growth factors which bind to and activate the EGF receptor. Since cultured mesangial cells synthesize HB-EGF and this cytokine is a potent mitogen for smooth muscle cells (SMC), a cell type similar to mesangial cells, we attempted to determine (1) whether HB-EGF mRNA is present in the proliferative phase of experimental mesangial proliferative glomerulonephritis, and (2) some of the factors which regulate its synthesis by mesangial cells. In this study we demonstrate that cultured rat mesangial cells (RMC) express HB-EGF mRNA and that transcript levels are markedly increased by serum with maximal induction occurring within 2 h. Stimulation with individual cytokines (EGF, TGF-alpha, PDGF, TGF-beta and TNF-alpha), by contrast, had only a minor effect. The increase in HB-EGF mRNA levels following addition of serum was rapid, transient and independent of protein synthesis, features characteristic of immediate-early genes. In normal rat kidneys, there was no detectable glomerular expression of HB-EGF mRNA as determined by in situ hybridization, although occasional tubular cross sections were positive. Within 30 min after induction of the Thy-1.1 model, however, cells within the glomerulus and an increased number of tubules were positive. The number of positive glomerular and tubular cells increased progressively at days 1 and 4 post-induction, but declined by day 9 and had returned to background at day 15. Within the glomerulus, HB-EGF was expressed by cells of Bowman's capsule and cells within the glomerular tuft. Using (a) combined in situ hybridization and immunohistochemical staining of the same section and (b) staining of sequential sections by immunohistochemistry or in situ hybridization, it was found that intrinsic glomerular cells which did not stain with the macrophage marker ED-1 expressed HB-EGF mRNA. Although some were probably glomerular epithelial cells because of their peripheral location, it was uncertain whether mesangial cells were also positive. Future studies will be directed towards firmer identification of the glomerular cells expressing HB-EGF mRNA and to define the functional role of HB-EGF in the Thy-1.1 model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931982

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  5 in total

Review 1.  Epidermal growth factor receptor mediates injury in rapidly progressive glomerular disease.

Authors:  Sabine Brandt; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2012-03-24       Impact factor: 2.370

2.  Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats.

Authors:  L Feng; G E Garcia; Y Yang; Y Xia; F B Gabbai; O W Peterson; J A Abraham; R C Blantz; C B Wilson
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

3.  Alteration of podocytes in a murine model of crescentic glomerulonephritis.

Authors:  Valérie Besse-Eschmann; Michel Le Hir; Nicole Endlich; Karlhans Endlich
Journal:  Histochem Cell Biol       Date:  2004-08       Impact factor: 4.304

4.  Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action.

Authors:  L A Opanashuk; R J Mark; J Porter; D Damm; M P Mattson; K B Seroogy
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

5.  Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.

Authors:  Guillaume Bollée; Martin Flamant; Sandra Schordan; Cécile Fligny; Elisabeth Rumpel; Marine Milon; Eric Schordan; Nathalie Sabaa; Sophie Vandermeersch; Ariane Galaup; Anita Rodenas; Ibrahim Casal; Susan W Sunnarborg; David J Salant; Jeffrey B Kopp; David W Threadgill; Susan E Quaggin; Jean-Claude Dussaule; Stéphane Germain; Laurent Mesnard; Karlhans Endlich; Claude Boucheix; Xavier Belenfant; Patrice Callard; Nicole Endlich; Pierre-Louis Tharaux
Journal:  Nat Med       Date:  2011-09-25       Impact factor: 53.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.